When did Abraxane come out?: A Timeline of its FDA Approval and Expansion
•
4 min read
Abraxane, a unique albumin-bound paclitaxel formulation, received its first U.S. Food and Drug Administration (FDA) approval on January 7, 2005, for the treatment of metastatic breast cancer. This initial approval answered the pivotal question, "When did Abraxane come out?", paving the way for its use in other cancer treatments in the years that followed.
